Summary of the technology

Cognitive and behavioral measurements in mice, suitable for drug evaluation and medical device development in two animal models for brain injury in mice (minimal traumatic brain injury and blast-brain injury).
Project ID : 12-2011-200

Details of the Technology Offer

Blast Brain Injury: a combat zone-like mouse model. From the experimental lab to the war against terror and back to the lab.

Improvised explosive devices (IEDs) are one of the main causes for casualties among civilians and military personnel in the present war against terror. IEDs induce various degrees of cognitive, emotional and behavioral disturbances but the knowledge of the exact brain pathophysiology following exposure to blast is poorly understood. We have developed a blast injury model for mice that resembles, as much as possible, the conditions in the battlefield or at a terror-attack site. As such, the outcomes of the “real-life-like” exposure to the blast in our model may vary from severe to mild brain injury under controlled conditions for each mouse, and possible confounds are minimized. In the mild to moderate group no alterations in neurological assessment or brain gross pathology were found in the blasted mice.

At 7 days post blast, cognitive and behavioral tests revealed significantly decreased performance at both 4 and 7 meters distance from the blast. At 30 days post-blast, clear differences were found for animals at both distances in the object recognition test, and in the 7 m group in the Y maze test. Using MRI, T1 weighted images showed an increased BBB permeability one month post-blast. DTI analysis showed an increase in fractional anisotropy and a decrease in radial diffusivity. These results may represent myelin reorganization and axonal-outgrowth inhibition.

Cellular and biochemical studies are underway in order to further correlate these blast-induced cognitive and behavioral changes and to identify possible underlying mechanisms that may help develop treatment- and neuro-protective modalities. In a cutting edge set of recent experiments, groups of mice were implanted pre or post blast with ALZET mini pumps containing Ex-4. Ex-4 is a long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist, which comprises 39 amino acids, which can enter the brain and activates anti-apoptotic pathways. We used 2 different paradigms: 1) mini pumps were implanted immediately following trauma, and 2) mini pumps were implanted 48 hr prior to the exposure to blast. Behavioral tests were conducted at two times, 7 and 30 days post trauma using the novel object recognition test. In the pre-injury treatment groups, mice subjected to mTBI showed impaired cognitive behaviors that were reversed by Ex-4. In the novel object recognition test 7 days post injury these differences reached statistical significance. Alike differences were found when the mice were examined 30 days post trauma. Similar protection was found for groups that were treated with Ex-4 immediately following the injury. These findings may offer a new therapeutic strategy to treat damages induced by mTBI and blast. Further studies are investigating this disorder to gain better understanding of the mechanisms involved in mTBI as well as blast to optimize treatment.

Contact:

Chaim G. Pick, Ph.D
Chairman,
Department of Anatomy,
Tel-Aviv University, Sackler Faculty of Medicine,
Email:
pickc@post.tau.ac.il
Tel: +972-(0)3-640- 9247

Project manager

avi Wener
Research services

Project researchers

Chaim G. Pick
T.A.U Tel Aviv University, Medicine-Sackler Faculty
Medicine-Sackler Faculty - General Department

Unknown Researcher
,

Related Keywords

  • Energy Technology
  • Energy Storage and Transport
  • Energy production, transmission and conversion
  • Chemistry
  • Medical Technology / Biomedical Engineering
  • Veterinary Medicine
  • Water Management
  • Creative services
  • Computer Services
  • Biochemistry / Biophysics Market
  • Animal health
  • Energy Market
  • Water treatment equipment and waste disposal systems
  • Life Sciences and Biotechnology
  • Life Sciences and Biotechnology
  • Medical Imaging and Image Processing
  • medical devices
  • Medical Imaging and Image Processing
  • Pharmaceutical Indications
  • cns
  • Pharmaceutical Indications
  • neurodegenerative diseases
  • Life Sciences and Biotechnology
  • animal models
  • Pharmaceutical Indications
  • animal models
  • Pharmaceutical Indications
  • Experimental Models
  • Life Sciences and Biotechnology
  • Experimental Models

About RAMOT at Tel Aviv University Ltd.

Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.

RAMOT at Tel Aviv University Ltd.

Never miss an update from RAMOT at Tel Aviv University Ltd.

Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide

RAMOT at Tel Aviv University Ltd.

Send a request for information
to RAMOT at Tel Aviv University Ltd.

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support